Table 1.
Trials | Country | Colonoscopy indication | Exclusion criteria |
N
(total) |
Defined age for patients included | Patients allocated to nurse participation | Patients allocated to colonoscopist alone |
| |||||||
Lee et al., 2011 [12] | Korea | Asymptomatic average risk individuals for screening colonoscopy | (1) GI bleeding, history of colorectal surgery, IBD, hereditary colorectal cancer, or polyposis syndrome and inability to provide consent; failed intubation and inadequate withdrawal time | 791 | ≥50 | 407 | 384 |
| |||||||
Kim et al., 2012 [13] | Korea | Average risk patients for screening colonoscopy | (1) Symptoms for lower gastrointestinal tract disease; (2) family history of CRC; (3) personal history of CRC, polyps, or IBD; (4) history of a colorectal examination within 5 years or colorectal surgery; (5) failed to reach the cecum | 383 | ≥50 | 192 | 191 |
| |||||||
Aslanian et al., 2013 [14] | USA | Patients for outpatient screening colonoscopy | IBD, hereditary colorectal cancer syndromes | 502 | None | 253 | 249 |